Cargando…
BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma
BACKGROUND: Endometrial carcinoma (EC) is one of the three major malignant tumors of the female reproductive system. In recent years, the incidence and mortality rate of EC have increased. B-cell translocation gene 1 (BTG1) is an anti-proliferation gene that regulates the occurrence and development...
Autores principales: | Li, Yibing, Huo, Jianing, He, Junjian, Zhang, Yunzheng, Ma, Xiaoxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542768/ https://www.ncbi.nlm.nih.gov/pubmed/33041670 http://dx.doi.org/10.1186/s12935-020-01591-3 |
Ejemplares similares
-
LncRNA MONC suppresses the malignant phenotype of Endometrial Cancer Stem Cells and Endometrial Carcinoma Cells by regulating the MiR-636/GLCE axis
por: Li, Yibing, et al.
Publicado: (2021) -
Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
por: Zhou, Cankun, et al.
Publicado: (2020) -
Bioinformatics Identification of the Expression and Clinical Significance of E2F Family in Endometrial Cancer
por: Zhang, YunZheng, et al.
Publicado: (2020) -
Establishment of a novel cell cycle-related prognostic signature predicting prognosis in patients with endometrial cancer
por: Liu, Jinhui, et al.
Publicado: (2020) -
MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial–mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells
por: Li, Yibing, et al.
Publicado: (2018)